PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
Petros Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.00+0.00 (+5.56%)
Close on Oct 19, 2026
- Market cap
- $135.07K
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Petros Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 30, 2026 | Sep 30, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2026 | Jun 18, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2026 | Jun 5, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Apr 15, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 1, 2026 | Jan 2, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 3, 2025 | Nov 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 29, 2025 | Sep 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 16, 2025 | Jun 20, 2025 | SEC EDGAR |
| Current report | 8-K | May 20, 2025 | May 21, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 28, 2025 | May 2, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 8, 2025 | Apr 11, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 5, 2025 | Apr 9, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 31, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 10, 2025 | Mar 18, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 17, 2025 | Feb 21, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 23, 2025 | Jan 24, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2024 | Dec 16, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 20, 2024 | Nov 21, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Nov 20, 2024 | Oct 25, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 16, 2024 | Oct 18, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 11, 2024 | Oct 17, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2024 | Oct 4, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 16, 2024 | Sep 19, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 14, 2024 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2023 | May 31, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 15, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Apr 1, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 21, 2024 | Mar 22, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2024 | Jan 12, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 29, 2023 | Dec 29, 2023 | SEC EDGAR |
| Current report | 8-K | Dec 21, 2023 | Dec 28, 2023 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 29, 2023 | Nov 30, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 15, 2023 | SEC EDGAR |
| Current report | 8-K | Sep 29, 2023 | Oct 2, 2023 | SEC EDGAR |